{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-09-16",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "product_ndc": "0480-3667",
      "generic_name": "liraglutide",
      "labeler_name": "Teva Pharmaceuticals USA, Inc.",
      "brand_name": "Liraglutide",
      "active_ingredients": [
        {
          "name": "LIRAGLUTIDE",
          "strength": "6 mg/mL"
        }
      ],
      "finished": true,
      "packaging": [
        {
          "package_ndc": "0480-3667-20",
          "description": "2 SYRINGE, PLASTIC in 1 CARTON (0480-3667-20)  / 3 mL in 1 SYRINGE, PLASTIC (0480-3667-19)",
          "marketing_start_date": "20240624",
          "sample": false
        },
        {
          "package_ndc": "0480-3667-22",
          "description": "3 SYRINGE, PLASTIC in 1 CARTON (0480-3667-22)  / 3 mL in 1 SYRINGE, PLASTIC (0480-3667-19)",
          "marketing_start_date": "20240624",
          "sample": false
        }
      ],
      "listing_expiration_date": "20271231",
      "openfda": {
        "manufacturer_name": [
          "Teva Pharmaceuticals USA, Inc."
        ],
        "rxcui": [
          "897122"
        ],
        "spl_set_id": [
          "14bf9812-14ee-46ce-93b1-686e4906cbbc"
        ],
        "is_original_packager": [
          true
        ],
        "nui": [
          "N0000178480",
          "M0160181",
          "N0000020058"
        ],
        "pharm_class_epc": [
          "GLP-1 Receptor Agonist [EPC]"
        ],
        "pharm_class_cs": [
          "Glucagon-Like Peptide 1 [CS]"
        ],
        "pharm_class_moa": [
          "Glucagon-like Peptide-1 (GLP-1) Agonists [MoA]"
        ],
        "unii": [
          "839I73S42A"
        ]
      },
      "marketing_category": "NDA AUTHORIZED GENERIC",
      "dosage_form": "INJECTION",
      "spl_id": "57c9f463-a1b8-4efa-8982-40175cf6cf4f",
      "product_type": "HUMAN PRESCRIPTION DRUG",
      "route": [
        "SUBCUTANEOUS"
      ],
      "marketing_start_date": "20240624",
      "product_id": "0480-3667_57c9f463-a1b8-4efa-8982-40175cf6cf4f",
      "application_number": "NDA022341",
      "brand_name_base": "Liraglutide",
      "pharm_class": [
        "GLP-1 Receptor Agonist [EPC]",
        "Glucagon-Like Peptide 1 [CS]",
        "Glucagon-like Peptide-1 (GLP-1) Agonists [MoA]"
      ]
    }
  ]
}